Relationship between plasma selenium concentrations and lower genital tract levels of HIV-1 RNA and interleukin type 1β

European Journal of Clinical Nutrition

Volumn 61, Issue 4, 2007, Pages 542-547

  Kupka, R ^a   Msamanga, G I ^b   Xu, C ^c   Anderson, D ^c   Hunter, D ^a   Fawzi, W W ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; INTERLEUKIN 1BETA; MULTIVITAMIN; RETINOL; SELENIUM; VIRUS RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PLACENTAL TRANSFER; PREGNANT WOMAN; RISK ASSESSMENT; RISK FACTOR; SELENIUM DEFICIENCY; TANZANIA; VAGINAL LAVAGE; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION; VITAMIN SUPPLEMENTATION;

ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-1BETA; NUTRITIONAL STATUS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RNA, VIRAL; SELENIUM; TANZANIA; VAGINA; VIRUS SHEDDING;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34247215666     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602567     Document Type: Article

References (27)

1. Baeten JM, Mostad SB, Hughes MP, Overbaugh J, Bankson DD, Mandaliya K et al. (2001). Selenium deficiency is associated with shedding of HIV-1-infected cells in the female genital tract. J Acquir Immune Defic Syndr 26, 360-364.
2. Burton GW, Ingold KU (1984). beta-Carotene: An unusual type of lipid antioxidant. Science 224, 569-573.
3. Deagan JT, Butler JA, Zachara A, Whanger PD (1993). Determination of the distribution of selenium between glutathione peroxidase, selenoprotein P, and albumin in plasma. Anal Biochem 208, 176-181.
4. Diamond AM, Hu YJ, Mansur DB (2001). Glutathione peroxidase and viral replication: Implications for viral evolution and chemoprevention. Biofactors 14, 205-210.
5. Drain PK, Baeten JM, Overbaugh J, Wener MH, Bankson DD, Lavreys L et al. (2006). Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women. BMC Infect Dis 6 85.
6. Fawzi W, Msamanga G, Antelman G, Xu C, Hertzmark E, Spiegelman D et al. (2004a). Effect of prenatal vitamin supplementation on lower-genital levels of HIV type 1 and interleukin type 1 beta at 36 weeks of gestation. Clin Infect Dis 38, 716-722.
7. Fawzi WW, Msamanga G, Hunter D, Urassa E, Renjifo B, Mwakagile D et al. (2000). A randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Def Syndr 23, 246-254.
8. Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, McGrath N, Mwakagile D et al. (1998). Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 351, 1477-1482.
9. Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E et al. (2004b). A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 351, 23-32.
10. Feldman JG, Burns DN, Gange SJ, Bacchetti P, Cohen M, Anastos K et al. (2000). Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study. AIDS 14, 863-870.
11. Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE et al. (2003). Serun albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr 33, 66-73.
12. Fichorova RN, Tucker LD, Anderson DJ (2001). The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 184, 418-428.
13. Kitano K, Baldwin GC, Raines MA, Golde DW (1990). Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains. Blood 76, 1980-1988.
14. Kupka R, Garland M, Msamanga G, Spiegelman D, Hunter D, Fawzi W (2005). Selenium status, pregnancy outcomes, and mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 39, 203-210.
15. MacDonald KS, Malonza I, Chen DK, Nagelkerke NJ, Nasio JM, Ndinya-Achola J et al. (2001). Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. AIDS 15, 635-639.
16. Mason M, Morris J, Spate V, Baskett C, Nichols T, Horsman T et al. (1998). Comparison of whole blood, plasma, and nails as monitors for the dietary intake of selenium. J Radioanal Nucl Chem 236, 29-34.
17. McClelland RS, Baeten JM, Overbaugh J, Richardson BA, Mandaliya K, Emery S et al. (2004). Micronutrient supplementation increases genital tract shedding of HIV-1 in women: Results of a randomized trial. J Acquir Immune Defic Syndr 37, 1657-1663.
18. Miettinen O (1985). Theoretical Epidemiology. John Wiley & Sons: New York.
19. Montano M, Russell M, Gilbert P, Thior I, Lockman S, Shapiro R et al. (2003). Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers. J Infect Dis 188, 406-413.
20. Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, Mandaliya K et al. (1997). Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 350, 922-927.
21. Neve J (2000). New approaches to assess selenium status and requirement. Nutr Rev 58, 363-369.
22. Pace GW, Leaf CD (1995). The role of oxidative stress in HIV disease. Free Radic Biol Med 19, 523-528.
23. Rayman MP (2002). The argument for increasing selenium intake. Proc Nutr Soc 61, 203-215.
24. Tuomala RE, O'Driscoll PT, Bremer JW, Jennings C, Xu C, Read JS et al. (2003). Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis 187, 375-384.
25. Turpin JA, Vargo M, Meltzer MS (1992). Enhanced HIV-1 replication in retinoid-treated monocytes. Retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression. J Immunol 148, 2539-2546.
26. UNAIDS (2005). AIDS Epidemic Update. UNAIDS: Geneva, Switzerland.
27. Wang CC, McClelland RS, Overbaugh J, Reilly M, Panteleeff DD, Mandaliya K et al. (2004). The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 18, 205-209.